Cytomegalovirus Infection and Cryptococcal Infection in Patient with Immunosuppression with Myasthenia Gravis
NEJM 395:804-815, Ankomah,P.O.,et al, 2026
Accuracy of Antibody Testing in Myasthenia Gravis
Neurol 107:e218301, Giannoccaro,M.P.,et al, 2026
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006
Development of Generalized Disease at 2 Years in Patients with Ocular Myasthenia Gravis
Arch Neurol 60:243-248, Kupersmith,M.J.,et al, 2003
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Acetylcholine Receptor Antibodies in Juvenile Myasthenia Gravis
Neurol 43:977-982, Andrews,P.I.,et al, 1993
Seronegative Generalized Myasthenia Gravis:Low Frequency of Thymic Pathology
Neurol 42:586-589, Verma,P.K.&Oger,J-F., 1992
Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991
Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978
Serum Antibodies to Cytomegalovirus in Myasthenia Gravis:Effects of Thymectomy & Steroids
Neurol 28:273, Tindall,R.S.A.,et al, 1978
Penicillamine-associated Myasthenia Gravis, Antiacetylcholine Receptor & Antistriational Antibodies
Am J Med 63:689, Masters,C.L.,et al, 1977